Trials / Completed
CompletedNCT01360424
Teriparatide Treatment in Patients With Inherited Osteoporosis
Efficacy of Teriparatide Treatment in Patients With New Forms of Inherited Low-Turnover Osteoporosis
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Helsinki University Central Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to analyse efficacy of teriparatide treatment in patients with new forms of inherited low-turnover osteoporosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Teriparatide | Daily administration of teriparatide 20 ug s.c. for 24 months |
Timeline
- Start date
- 2011-05-01
- Primary completion
- 2013-11-01
- Completion
- 2013-11-01
- First posted
- 2011-05-25
- Last updated
- 2015-09-29
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT01360424. Inclusion in this directory is not an endorsement.